BIOMARIN PHARMACEUTICAL INC
Total Trades
105
Buys
1
Sells
62
Largest Trade
N/A
Insiders
13
Institutional Funds
451
Inst. Value
$1M+
Activist Filings
23
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Mueller Brian | CFO | SELL | $100K–$500K | 3K | $114.50 | Jan 18, 2023 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 3K | $63.10 | Jan 18, 2023 |
| Mueller Brian | CFO | SELL | $100K–$500K | 3K | $107.50 | Dec 15, 2022 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 3K | $63.10 | Dec 15, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $100K–$500K | 1K | $106.89 | Dec 15, 2022 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 6K | $67.81 | Dec 7, 2022 |
| Mueller Brian | CFO | SELL | $500K+ | 7K | $104.50 | Dec 7, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $100K–$500K | 2K | $103.98 | Dec 7, 2022 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 4K | $67.81 | Nov 29, 2022 |
| Mueller Brian | CFO | SELL | $500K+ | 5K | $98.73 | Nov 29, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $100K–$500K | 3K | $86.12 | Nov 4, 2022 |
| Alles Mark J | Director | BUY | $100K–$500K | 4K | $86.75 | Nov 2, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $100K–$500K | 2K | $86.55 | Nov 2, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $100K–$500K | 4K | $89.89 | Oct 19, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $500K+ | 7K | $94.95 | Aug 16, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $100K–$500K | 3K | $95.62 | Aug 12, 2022 |
| Davis George Eric | EVP | EXERCISE | $1M+ | 48K | $67.81 | Aug 12, 2022 |
| Davis George Eric | EVP | SELL | $1M+ | 51K | $95.96 | Aug 12, 2022 |
| Guyer Charles Greg | EVP | SELL | $500K+ | 6K | $96.56 | Aug 10, 2022 |
| Mueller Brian | CFO | SELL | $100K–$500K | 4K | $94.50 | Aug 9, 2022 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 4K | $67.81 | Aug 9, 2022 |
| Mueller Brian | CFO | SELL | $500K+ | 7K | $89.50 | Jul 12, 2022 |
| Davis George Eric | EVP | SELL | $500K+ | 7K | $90.00 | Jul 11, 2022 |
| Ajer Jeffrey Robert | EVP | GRANT | $15K–$50K | 340 | $62.41 | Jun 1, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $100K–$500K | 1K | $78.94 | Jun 1, 2022 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 30K | $37.46 | May 10, 2022 |
| BIENAIME JEAN JACQUES | CEO | GRANT | $15K–$50K | 341 | $62.41 | May 10, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 30K | $82.05 | May 10, 2022 |
| Mueller Brian | CFO | GRANT | $15K–$50K | 340 | $62.41 | May 6, 2022 |
| Mueller Brian | CFO | SELL | $500K+ | 12K | $84.50 | May 6, 2022 |
| Mueller Brian | CFO | EXERCISE | $100K–$500K | 12K | $37.46 | May 6, 2022 |
| MEIER RICHARD A | Director | EXERCISE | $100K–$500K | 9K | $37.46 | May 4, 2022 |
| MEIER RICHARD A | Director | SELL | $100K–$500K | 4K | $82.09 | May 4, 2022 |
| Davis George Eric | EVP | SELL | $1M+ | 15K | $80.38 | May 4, 2022 |
| Davis George Eric | EVP | GRANT | $15K–$50K | 341 | $62.41 | May 4, 2022 |
| Davis George Eric | EVP | EXERCISE | $500K+ | 15K | $37.46 | May 4, 2022 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $500K+ | 25K | $37.46 | May 3, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 25K | $83.42 | May 3, 2022 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $500K+ | 20K | $37.46 | Apr 21, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 20K | $81.91 | Apr 21, 2022 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $100K–$500K | 10K | $37.46 | Apr 19, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $500K+ | 10K | $83.66 | Apr 19, 2022 |
| LAWLIS V BRYAN | Director | SELL | $100K–$500K | 4K | $83.66 | Apr 19, 2022 |
| LAWLIS V BRYAN | Director | EXERCISE | $100K–$500K | 4K | $37.46 | Apr 19, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $50K–$100K | 1K | $82.47 | Apr 14, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $100K–$500K | 3K | $79.49 | Apr 1, 2022 |
| Ajer Jeffrey Robert | EVP | SELL | $500K+ | 8K | $81.58 | Mar 25, 2022 |
| Davis George Eric | EVP, General Counsel | SELL | $100K–$500K | 6K | $81.29 | Mar 24, 2022 |
| BIENAIME JEAN JACQUES | CEO | SELL | $1M+ | 30K | $77.69 | Mar 15, 2022 |
| BIENAIME JEAN JACQUES | CEO | EXERCISE | $1M+ | 30K | $37.46 | Mar 15, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 451 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DODGE & COX | 14.6M | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 14.5M | $1M+ | SH |
| NORGES BANK | 7.5M | $1M+ | SH |
| STATE STREET CORP | 7.5M | $1M+ | SH |
| VIKING GLOBAL INVESTORS LP | 6.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 2.9M | $1M+ | SH |
| Capital Research Global Investors | 2.5M | $1M+ | SH |
| Deep Track Capital, LP | 2.3M | $1M+ | SH |
| Squarepoint Ops LLC | 1.8M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.4M | $1M+ | SH |
| DnB Asset Management AS | 1.4M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.3M | $1M+ | SH |
| Soleus Capital Management, L.P. | 1.3M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.3M | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 1.2M | $1M+ | SH |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.0M | $1M+ | SH |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.1M | $1M+ | SH |
| Brandywine Global Investment Management, LLC | 946K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jan 21, 2026
9.1%
17.6M shares
SC 13G/A · Nov 14, 2025
4.3%
8.3M shares
SC 13G/A · Aug 14, 2025
6.4%
12.3M shares
SC 13G/A · Aug 14, 2025
8.2%
15.8M shares
Capital Research Global Investors
SC 13G/A · May 13, 2025
4.8%
9.2M shares
SC 13G/A · Apr 29, 2025
10.8%
20.6M shares
Capital Research Global Investors
SC 13G/A · Feb 13, 2025
6.8%
13.0M shares
SC 13G · Sep 30, 2024
5.1%
9.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jul 10, 2024
10.0%
19.0M shares
SC 13G/A · Jul 8, 2024
12.0%
22.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.6%
18.0M shares
SC 13G/A · Feb 13, 2024
7.4%
1.4B shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 12, 2024
9.8%
18.4M shares
Capital Research Global Investors 95-1411037
SC 13G · Feb 9, 2024
5.7%
10.8M shares
SC 13G/A · Jan 26, 2024
7.8%
14.7M shares
SC 13G/A · Feb 14, 2023
7.7%
14.4M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 13, 2023
3.0%
5.7M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 9, 2023
9.5%
17.6M shares
SC 13G/A · Feb 3, 2023
8.2%
15.2M shares
SC 13G/A · Mar 11, 2022
7.6%
14.0M shares
SC 13G/A · Feb 14, 2022
8.1%
14.8M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 10, 2022
9.7%
17.8M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Jan 10, 2022
6.9%
12.7M shares